Sinclair Pharma is to buy the US Food & Drug Administration-approved Refine Support System from Refine for up to $11.3m, according to CEO Hana Stewart-Smith. The product, usually used in breast cosmetic and reconstructive procedures, is a flexible suture-mesh-anchor system that lifts and supports soft tissue. "Following future regulatory approvals, we will launch the product into the other large aesthetic markets around the world, with the initial focus on Europe and Brazil," said Spooner.
Sinclair Pharma is to buy the US Food & Drug Administration-approved Refine Support System from Refine for up to $11.3m, according to CEO Chris Spooner. The product, usually used in breast cosmetic and reconstructive procedures, is a flexible suture-mesh-anchor system that lifts and supports soft tissue. "Following future regulatory approvals, we will launch the product into the other large aesthetic markets around the world, with the initial focus on Europe and Brazil," said Spooner.